Qian Xie Selected Research

Carcinoma (Carcinomatosis)

1/2022	Apatinib inhibits paclitaxel resistance of gastric carcinoma cells through VEGFR2 pathway.
1/2022	Corrigendum: Cost-effectiveness of avelumab maintenance therapy plus best supportive care vs. best supportive care alone for advanced or metastatic urothelial carcinoma.
1/2022	Cost-Effectiveness of Avelumab Maintenance Therapy Plus Best Supportive Care vs. Best Supportive Care Alone for Advanced or Metastatic Urothelial Carcinoma.
10/2013	Synergetic effect of SLN-curcumin and LDH-5-Fu on SMMC-7721 liver cancer cell line.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qian Xie Research Topics

Disease

56	Neoplasms (Cancer) 04/2024 - 08/2003
10	Infections 12/2023 - 11/2004
10	Hepatocellular Carcinoma (Hepatoma) 10/2023 - 08/2003
10	Brain Ischemia (Cerebral Ischemia) 09/2023 - 01/2018
9	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 11/2004
8	Inflammation (Inflammations) 09/2023 - 01/2015
8	Cerebral Infarction 09/2023 - 01/2017
7	Glioma (Gliomas) 02/2024 - 01/2017
7	Neoplasm Metastasis (Metastasis) 11/2021 - 08/2003
7	Stroke (Strokes) 08/2021 - 01/2017
6	Ischemic Stroke 09/2023 - 11/2020
6	Virus Diseases (Viral Diseases) 07/2023 - 12/2012
6	Stomach Neoplasms (Stomach Cancer) 01/2021 - 11/2004
5	Breast Neoplasms (Breast Cancer) 06/2022 - 01/2018
4	Osteoarthritis 01/2024 - 01/2023
4	Body Weight (Weight, Body) 10/2023 - 01/2021
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 01/2022
4	Carcinoma (Carcinomatosis) 01/2022 - 10/2013
4	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 08/2011
3	Melanoma (Melanoma, Malignant) 12/2023 - 01/2016
3	Type 2 Diabetes Mellitus (MODY) 10/2023 - 01/2022
3	Cerebrovascular Disorders (Cerebrovascular Occlusion) 08/2023 - 01/2021
3	Liver Neoplasms (Liver Cancer) 12/2022 - 10/2013
3	Asthma (Bronchial Asthma) 01/2016 - 01/2012
2	Hypertension (High Blood Pressure) 01/2024 - 11/2021
2	Human Influenza (Influenza) 12/2023 - 11/2021
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 09/2023 - 01/2021
2	Hyperglycemia 01/2023 - 01/2022
2	Sepsis (Septicemia) 12/2022 - 01/2022
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 03/2022 - 11/2021
2	Glucose Intolerance 01/2022 - 01/2020
2	Lung Neoplasms (Lung Cancer) 01/2022 - 10/2015
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 01/2021
2	Ischemia 01/2022 - 08/2021
2	Wounds and Injuries (Trauma) 11/2021 - 12/2016
2	Hemorrhage 11/2021 - 12/2016
2	Thyroid Neoplasms (Thyroid Cancer) 10/2021 - 02/2018
2	Brain Neoplasms (Brain Tumor) 01/2021 - 01/2017

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2009
11	isoborneol (borneol)IBA 09/2023 - 06/2018
9	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2020 - 11/2004
7	VaccinesIBA 01/2019 - 06/2011
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2023 - 11/2012
4	Antiviral Agents (Antivirals)IBA 07/2023 - 01/2016
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2012
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2020
4	Small Interfering RNA (siRNA)IBA 01/2020 - 11/2004
3	GadoliniumIBA 02/2024 - 01/2019
3	Amino Acids FDA Link 12/2023 - 08/2020
3	CytokinesIBA 10/2023 - 01/2012
3	MicroRNAs (MicroRNA)IBA 04/2023 - 10/2015
3	Interleukin-6 (Interleukin 6)IBA 03/2023 - 12/2022
3	triphenyltetrazoliumIBA 03/2023 - 01/2022
3	AcidsIBA 01/2023 - 11/2020
3	Cisplatin (Platino)FDA LinkGeneric 11/2022 - 07/2022
3	LigandsIBA 01/2022 - 11/2004
3	Neuroprotective AgentsIBA 01/2021 - 01/2021
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020 - 11/2004
3	Neutralizing AntibodiesIBA 12/2018 - 10/2009
3	tanespimycin (17AAG)IBA 10/2014 - 12/2008
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2024 - 10/2022
2	pyrimidineIBA 12/2023 - 11/2021
2	CateninsIBA 12/2023 - 11/2020
2	Chimeric Antigen ReceptorsIBA 10/2023 - 11/2020
2	Iodoacetic AcidIBA 07/2023 - 01/2023
2	Interleukin-4 (Interleukin 4)IBA 03/2023 - 01/2012
2	ginsenoside Rg1IBA 01/2023 - 01/2021
2	Insulin (Novolin)FDA Link 01/2023 - 11/2021
2	NestinIBA 01/2023 - 01/2020
2	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 01/2023 - 01/2022
2	AntioxidantsIBA 01/2023 - 01/2022
2	Hyaluronic Acid (Hyaluronan)IBA 01/2023 - 07/2020
2	EnzymesIBA 01/2023 - 01/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 01/2023
2	phytochlorinIBA 01/2023 - 04/2021
2	Malondialdehyde (Propanedial)IBA 01/2023 - 12/2022
2	B7-H1 AntigenIBA 12/2022 - 01/2021
2	Caspase 3 (Caspase-3)IBA 12/2022 - 01/2020
2	SolutionsIBA 11/2022 - 11/2008
2	Indicators and Reagents (Reagents)IBA 11/2022 - 07/2013
2	Hormones (Hormone)IBA 06/2022 - 11/2017
2	Therapeutic UsesIBA 03/2022 - 01/2017
2	LipidsIBA 01/2022 - 12/2012
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2022 - 01/2017
2	avelumabIBA 01/2022 - 01/2022
2	EndonucleasesIBA 11/2021 - 11/2021
2	Hemostatics (Antihemorrhagics)IBA 11/2021 - 12/2016
2	gamabufotalinIBA 11/2021 - 10/2019
2	Sirtuin 1IBA 10/2021 - 02/2018
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 09/2021 - 01/2019
2	benzoinumIBA 01/2021 - 11/2020

Therapy/Procedure

36	Therapeutics 12/2023 - 11/2004
9	Drug Therapy (Chemotherapy) 12/2023 - 10/2019
9	Chinese Traditional Medicine (Traditional Chinese Medicine) 10/2022 - 09/2014
8	Immunotherapy 12/2023 - 01/2016
3	Intravenous Administration 01/2023 - 07/2020
2	Resuscitation 01/2023 - 01/2021
2	Lasers (Laser) 01/2023 - 11/2004
2	Radiotherapy 11/2021 - 01/2021
2	Photothermal Therapy 11/2021 - 10/2019